Variable receptors controlling activation and inhibition of NK cells

Current Opinion in Immunology

Volumn 14, Issue 5, 2002, Pages 615-621

  Eriksson, Kristina ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RECEPTOR; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; HAPLOTYPE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MOLECULAR EVOLUTION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

EID: 0036774998     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00380-1     Document Type: Review

References (102)

1. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 19:2001;291-330.
2. Vilches C., Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 20:2002;217-251.
3. Lanier L.L. On guard - activating NK cell receptors. Nat Immunol. 2:2001;23-27.
4. Parham P (Ed): Natural killer and leucocyte receptor complexes. In Immunol Rev 2001, 181:5-289.
5. Westgaard I.H., Berg S.F., Orstavlk S., Fossum S., Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol. 28:1998;1-8.
6. Barten R., Trowsdale J. The human Ly-49L gene. Immunogenetics. 49:1999;731-734.
7. Mager D.L., McQueen K.L., Wee V., Freeman J.D. Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons. Curr Biol. 11:2001;626-630. This study demonstrates that an intact Ly49-like gene is conserved in primates and that the gene probably became inactivated before the divergence of gorilla, chimpanzee and humans eight millions years ago. Evidence that multiple KIR genes exist in the baboon is also presented.
8. McQueen K.L., Wilhelm B.T., Harden K.D., Mager D.L. Evolution of NK receptors: a single Ly49 and multiple KIR genes in the cow. Eur J Immunol. 32:2002;810-817. This is the first report that KIR-like genes are present in non-primate mammals. A single intact Ly49-like gene and multiple KIR genes from cattle are described.
9. Guethlein L.A., Flodin L., Adams E.J., Parham P. NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the co-evolution of killer cell Ig-like receptors and MHC-C. J Immunol. 169:2002;220-229.
10. Houchins J.P., Yabe T., McSherry C., Bach F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 173:1991;1017-1020.
11. Vance R.E., Tanamachi D.M., Hanke T., Raulet D.H. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol. 27:1997;3236-3241.
12. Lohwasser S., Hande P., Mager D.L., Takei F. Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells. Eur J Immunol. 29:1999;755-761.
13. Silver E.T., Lau J.C., Kane K.P. Molecular cloning of mouse NKG2A and C. Immunogenetics. 49:1999;727-730.
14. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J Exp Med. 188:1998;1841-1848.
15. Vance R.E., Jamieson A.M., Raulet D.H. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med. 190:1999;1801-1812.
16. Khakoo S.I., Rajalingam R., Shum B.P., Weidenbach K., Flodin L., Muir D.G., Canavez F., Cooper S.L., Valiante N.M., Lanier L.L., et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity. 12:2000;687-698.
17. LaBonte M.L., Levy D.B., Letvin N.L. Characterization of rhesus monkey CD94/NKG2 family members and identification of novel transmembrane-deleted forms of NKG2-A, B, C, and D. Immunogenetics. 51:2000;496-499.
18. Kravitz R.H., Grendell R.L., Slukvin I.I., Golos T.G. Selective expression of NKG2-A and NKG2-C mRNAs and novel alternative splicing of 5′ exons in rhesus monkey decidua. Immunogenetics. 53:2001;69-73.
19. Shum B.P., Flodin L.R., Muir D.G., Rajalingam R., Khakoo S.I., Cleland S., Guethlein L.A., Uhrberg M., Parham P. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol. 168:2002;240-252.
20. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813-818.
21. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
22. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199-5204.
23. Salcedo M., Bousso P., Ljunggren H.G., Kourilsky P., Abastado J.P. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur J Immunol. 28:1998;4356-4361.
24. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7:1997;739-751.
25. Raulet D.H., Held W., Correa I., Dorfman J.R., Wu M.F., Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev. 155:1997;41-52.
26. Kubota A., Kubota S., Lohwasser S., Mager D.L., Takei F. Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol. 163:1999;212-216.
27. Gumperz J.E., Valiante N.M., Parham P., Lanier L.L., Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J Exp Med. 183:1996;1817-1827.
28. Frohn C., Schlenke P., Kirchner H. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology. 92:1997;567-570.
29. Shilling H.G., Young N., Guethlein L.A., Cheng N.W., Gardiner C.M., Tyan D., Parham P. Genetic control of human NK cell repertoire. J Immunol. 169:2002;239-247.
30. Held W., Raulet D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med. 185:1997;2079-2088.
31. Salcedo M., Diehl A.D., Olsson-Alheim M.Y., Sundback J., Van Kaer L., Karre K., Ljunggren H.G. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol. 158:1997;3174-3180.
32. Khoo N.K., Fahlen L., Sentman C.L. Modulation of Ly49A receptors on mature cells to changes in major histocompatibility complex class I molecules. Immunology. 95:1998;126-131.
33. Hanke T., Takizawa H., Raulet D.H. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol. 31:2001;3370-3379. This group extends previous findings that the inhibitory Ly49 repertoire is shaped by interactions with MHC. They propose the regulated sequential model, which predicts that expression of one self-specific receptor will inhibit subsequent expression of other inhibitory receptors.
34. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., Tyan D., Lanier L.L., Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:1997;753-763.
35. Toneva M., Lepage V., Lafay G., Dulphy N., Busson M., Lester S., Vu-Trien A., Michaylova A., Naumova E., McCluskey J., et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens. 57:2001;358-362. The authors examine KIR diversity in three populations and show that each differs in its gene associations and putative KIR haplotypes. Australian aborigines were shown to have a higher frequency of B haplotypes as compared with the other Caucasian populations studied.
36. Norman P.J., Stephens H.A., Verity D.H., Chandanayingyong D., Vaughan R.W. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics. 52:2001;195-205.
37. Norman P.J., Carrington C.V., Byng M., Maxwell L.D., Curran M.D., Stephens H.A., Chandanayingyong D., Verity D.H., Hameed K., Ramdath D.D., et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun. 3:2002;86-95. Lowresolution KIR genotyping methods were employed to determine that south-Asian populations have a higher frequency of KIR loci characteristic of B haplotypes. Two individuals lacking the KIR2DL4 gene at the genomic level were also described.
38. Shilling H.G., Guethlein L.A., Cheng N.W., Gardiner C.M., Rodriguez R., Tyan D., Parham P. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol. 168:2002;2307-2315. Highresolution genotyping analysis at four KIR loci was performed on 143 individuals from 34 families to determine that allelic polymorphism acts in combination with variable gene content to diversify individual KIR genotype.
39. Rajalingam R., Krausa P., Shilling H.G., Stein J.B., Balamurugan A., McGinnis M.D., Cheng N.W., Mehra N.K., Parham P. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics. 53:2002;1009-1019.
40. Rajalingam R., Hong M., Adams E.J., Shum B.P., Guethlein L.A., Parham P. Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med. 193:2001;135-146.
41. Hershberger K.L., Shyam R., Miura A., Letvin N.L. Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol. 166:2001;4380-4390.
42. Grendell R.L., Hughes A.L., Golos T.G. Cloning of rhesus monkey killer-cell Ig-like receptors (KIRs) from early pregnancy decidua. Tissue Antigens. 58:2001;329-334.
43. Martin A.M., Freitas E.M., Witt C.S., Christiansen F.T. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics. 51:2000;268-280.
44. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., Beck S., Trowsdale J. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA. 97:2000;4778-4783.
45. Valiante N.M., Lienert K., Shilling H.G., Smits B.J., Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev. 155:1997;155-164.
46. Gardiner C.M., Guethlein L.A., Shilling H.G., Pando M., Carr W.H., Rajalingam R., Vilches C., Parham P. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol. 166:2001;2992-3001.
47. McQueen K.L., Freeman J.D., Takei F., Mager D.L. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics. 48:1998;174-183.
48. Makrigiannis A.P., Anderson S.K. Ly49 gene expression in different inbred mouse strains. Immunol Res. 21:2000;39-47.
49. Silver E.T., Gong D., Hazes B., Kane K.P. Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d). J Immunol. 166:2001;2333-2341.
50. Mehta I.K., Wang J., Roland J., Margulies D.H., Yokoyama W.M. Ly49A allelic variation and MHC class I specificity. Immunogenetics. 53:2001;572-583. Variants of the inhibitory Ly49a gene were cloned from different mouse strains and allelic polymorphism was shown to have functional consequences with respect to inhibition of ligand-expressing targets.
51. d. J Immunol. 165:2000;1771-1781.
52. Makrigiannis A.P., Pau A.T., Schwartzberg P.L., McVicar D.W., Beck T.W., Anderson S.K. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics. 79:2002;437-444. The authors report the genomic organization of the Ly49 gene cluster in the inbred strain 129/J and show that it differs significantly from the Ly49 cluster in C57BL/6 mice. This report illustrates haplotypic diversity in the Ly49 receptor system.
53. Vilches C., Rajalingam R., Uhrberg M., Gardiner C.M., Young N.T., Parham P. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol. 164:2000;5797-5804.
54. Ortaldo J.R., Mason A.T., Winkler-Pickett R., Raziuddin A., Murphy W.J., Mason L.H. Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol. 66:1999;512-520.
55. Pietra G., Semino C., Cagnoni F., Boni L., Cangemi G., Frumento G., Melioli G. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically. J Med Virol. 62:2000;354-363.
56. null T cells.
57. Cantoni C., Verdiani S., Falco M., Pessino A., Cilli M., Conte R., Pende D., Ponte M., Mikaelsson M.S., Moretta L., et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980-1990.
58. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1999;1093-1100.
59. Rajagopalan S., Fu J., Long E.O. Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol. 167:2001;1877-1881. This study illustrates that KIR2DL4 has unique stimulatory properties as it can induce IFN-γ production, but not cytotoxicity, from resting NK cells. This report supports an activating role for KIR2DL4.
60. Faure M., Long E.O. KIR2DL4 (CD158d), an NK cell-cctivating receptor with inhibitory potential. J Immunol. 168:2002;6208-6214.
61. Yusa S., Catina T.L., Campbell K.S. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol. 168:2002;5047-5057.
62. King A., Burrows T., Verma S., Hiby S., Loke Y.W. Human uterine lymphocytes. Hum Reprod Update. 4:1998;480-485.
63. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA. 96:1999;5674-5679.
64. Allan D.S., Colonna M., Lanier L.L., Churakova T.D., Abrams J.S., Ellis S.A., McMichael A.J., Braud V.M. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med. 189:1999;1149-1156.
65. Ashkar A.A., Croy B.A. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol. 13:2001;235-241.
66. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065-2072.
67. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 188:1998;953-960.
68. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 190:1999;1505-1516.
69. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787-796.
70. Falco M., Cantoni C., Bottino C., Moretta A., Biassoni R. Identification of the rat homologue of the human NKp46 triggering receptor. Immunol Lett. 68:1999;411-414.
71. Biassoni R., Pessino A., Bottino C., Pende D., Moretta L., Moretta A. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol. 29:1999;1014-1020.
72. De Maria A., Biassoni R., Fogli M., Rizzi M., Cantoni C., Costa P., Conte R., Mavilio D., Ensoli B., Cafaro A., et al. Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells. Eur J Immunol. 31:2001;3546-3556.
73. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 409:2001;1055-1060. These researchers identify viral HAs as the ligands for the activating NKp46 receptor and show that ligand recognition requires sialylation of oligosaccharides on the receptor. This is the first report of a ligand for the NCRs.
74. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol. 31:2001;2680-2689. This group demonstrated that viral HAs are ligands for NKp44, but not NKp30. Ligand recognition was shown to require sialylation of NKp44 oligosaccharides.
75. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
76. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730-732.
77. Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., Spies T. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics. 53:2001;279-287.
78. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:2001;123-133. The human cytomegalovirus ULBPs were identified as ligands for the activating NKG2D receptor. ULBPs were shown to be distantly related to MHC class I molecules and to also bind UL16.
79. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA. 96:1999;6879-6884.
80. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumour cells and activation of NK cells and macrophages. Nat Immunol. 1:2000;119-126.
81. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
82. O'Callaghan C.A., Cerwenka A., Willcox B.E., Lanier L.L., Bjorkman P.J. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity. 15:2001;201-211.
83. Cerwenka A., Baron J.L., Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA. 98:2001;11521-11526. See annotation to [84•] .
84. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:2001;165-171. These groups of researchers [83•,84•] demonstrate that ectopic expression of the NKG2D ligands Rae-1 and H60 by tumor cells results in NK-cell-mediated lysis. These reports show that NK cells are able to kill targets expressing MHC class I, probably via an NKG2D-mediated mechanism.
85. Radaev S., Rostro B., Brooks A.G., Colonna M., Sun P.D. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity. 15:2001;1039-1049.
86. Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., Strong R.K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol. 2:2001;443-451.
87. Li P., McDermott G., Strong R.K. Crystal structures of RAE-1 beta and its complex with the activating immunoreceptor NKG2D. Immunity. 16:2002;77-86.
88. George T.C., Mason L.H., Ortaldo J.R., Kumar V., Bennett M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol. 162:1999;2035-2043.
89. d and activates natural killer cell cytotoxicity. J Exp Med. 189:1999;493-500.
90. Nakamura M.C., Naper C., Niemi E.C., Spusta S.C., Rolstad B., Butcher G.W., Seaman W.E., Ryan J.C. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor. J Immunol. 163:1999;4694-4700.
91. Idris A.H., Smith H.R., Mason L.H., Ortaldo J.R., Scalzo A.A., Yokoyama W.M. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci USA. 96:1999;6330-6335.
92. Furukawa H., Iizuka K., Poursine-Laurent J., Shastri N., Yokoyama W.M. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta(2)-microglobulin-deficient mice. J Immunol. 169:2002;126-136.
93. George T.C., Ortaldo J.R., Lemieux S., Kumar V., Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol. 163:1999;1859-1867.
94. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med. 171:1990;1469-1483.
95. Forbes C.A., Brown M.G., Cho R., Shellman G.R., Yokoyama W.M., Scalzo A.A. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics. 41:1997;406-413.
96. Depatie C., Muise E., Lepage P., Gros P., Vidal S.M. High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics. 39:1997;154-163.
97. Brown M.G., Zhang J., Du Y., Stoll J., Yokoyama W.M., Scalzo A.A. Localization on a physical map of the NKC-linked Cmv1 locus between Ly49b and the Prp gene cluster on mouse chromosome 6. J Immunol. 163:1999;1991-1999.
98. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet. 28:2001;42-45. See annotation to [99••].
99. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937. Lee et al. [98••] and Brown et al. [99••] independently show that MCMV susceptibility associates with deletion of the activating Ly49h gene in an MCMV-susceptible recombinant strain. These are the first reports that activating Ly49 genes are directly involved in resistance to infection.
100. + NK cell subset.
101. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326. The ligand for the activating Ly49H receptor is identified as the MCMV-encoded m157 protein, which is distantly related to other MHC class I molecules. m157 is also shown to bind to an inhibitory Ly49 molecule in the MCMV-susceptible 129/J.
102. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA. 99:2002;8826-8831.